Insight
Report
|
Nexavar is pursuing line extensions to tighten its grip on the HCC treatment market
Published By Datamonitor
|
$2000
|
Report
|
The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.
Published By Datamonitor
|
$2800
|
Report
|
The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.
Published By Datamonitor
|
$2800
|
Market Data
Interactive Model
|
This in-depth Excel databook covers the cardiovascular pipeline by company and phase.
Published By Datamonitor
|
$3800
|
Interactive Model
|
This in-depth Excel databook covers the CNS pipeline by company and phase.
Published By Datamonitor
|
$3800
|
Interactive Model
|
This in-depth Excel databook covers the cancer pipeline by company and phase.
Published By Datamonitor
|
$3800
|
Profiles
Company Profile
|
Actavis (or 'the company'), formerly known as Watson Pharmaceuticals, is an integrated global specialty pharmaceutical company focused on the development, manufacture, marketing, sale and distribution of generic, branded and biosimilar products. In January 2013, Watson Pharmaceuticals changed its name to Actavis, Inc. The company operates in the Americas, Europe and Asia. Actavis is headquartered in Parsippany, New Jersey, and employed 17,700 people as of December 31, 2012.
Published By MarketLine
|
$175
|
Company Profile
|
Forest Laboratories, Inc. (Forest Labs or 'the company') is a specialty pharmaceutical company engaged in the development, manufacture and sales of both branded and generic forms of ethical drug products and other healthcare products. It primarily focuses in the therapeutic areas of central nervous systems and cardiovascular. The company primarily operates in the US, where it is headquartered in New York City, New York. Forest Labs employed about 5,700 people as of March 31, 2012.
Published By MarketLine
|
$175
|
Company Profile
|
ImmunoGen (or 'the company') is a developer if targeted anticancer therapeutics using its targeted antibody payload (TAP) technology. The company's TAP technology uses a tumor-targeting monoclonal antibody to deliver a cancer-killing agent specifically to tumor cells. ImmunoGen is headquartered in Waltham, Massachusetts, and employed 245 people as of June 30, 2012.
Published By MarketLine
|
$175
|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.